The evaluation of kidney function using the Somatostatin (SSTR)-targeting radioligands 18F-SiFATATE, 68Ga-DOTATATE and 68Ga-DOTATOC in a theranostic setting

被引：0
|
作者：
Tiling, M. [1 ]
Holzgreve, A. [1 ]
Kunte, S. [1 ]
Sheikh, G. [1 ]
Unterrainer, M. [1 ,2 ]
Bartenstein, P. [1 ]
Delker, A. [1 ]
Unterrainer, L. [1 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Munich, Germany
[2] Die Radiol, Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0210
引用
收藏
页码：S513 / S514
页数：2
相关论文
共 50 条
  • [31] A Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in Pulmonary Neuroendocrine Tumors
    Kayani, Irfan
    Conry, Brendon G.
    Groves, Ashley M.
    Win, Thida
    Dickson, John
    Caplin, Martyn
    Bomanji, Jamshed B.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (12) : 1927 - 1932
  • [32] Metastatic Poorly Differentiated Thyroid Cancer With Heterogeneous Distribution of 18F-FDG, 68Ga-DOTATATE, and 68Ga-PSMA on PET/CT
    Civan, Caner
    Isik, Emine Goknur
    Simsek, Duygu Has
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (04) : E212 - E213
  • [33] 68Ga-DOTATOC Pictorial Essay of Various Recurrent Meningiomas Rejected for Treatment With 177Lu-DOTATATE Is There a Place for Another Theranostic Examination?
    Moreau, Aurelie
    Maureille, Aurelien
    Kryza, David
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (07) : 655 - 658
  • [34] Malignant insulinoma: 18F-DOPA and 68Ga-DOTATATE PET/CT and treatment with 177Lu-DOTATATE
    Erhamamci, S.
    Sager, S.
    Asa, S.
    Uslu, L.
    Akgun, E.
    Sonmezoglu, K.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2020, 39 (06): : 383 - 386
  • [35] Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT
    Jiale Hou
    Tingting Long
    Zhiyou He
    Ming Zhou
    Nengan Yang
    Dengming Chen
    Shan Zeng
    Shuo Hu
    EJNMMI Research, 11
  • [36] Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT
    Hou, Jiale
    Long, Tingting
    He, Zhiyou
    Zhou, Ming
    Yang, Nengan
    Chen, Dengming
    Zeng, Shan
    Hu, Shuo
    EJNMMI RESEARCH, 2021, 11 (01)
  • [37] Preliminary comparison of 68Ga-FAPI-46 against 18F-FDG, 68Ga-DOTATATE and 68Ga-Pentixafor PET/CT/ MR imaging in the assessment of various cancer types
    Dadgar, H.
    Al-Ibraheem, A.
    Haidar, M.
    Esmail, A. A.
    Al-Balooshi, B.
    Marafi, F.
    Al-Alawi, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S589 - S589
  • [38] Al18F-NOTA-Octreotide PET Imaging of the Somatostatin Receptor: First Comparison with 68Ga-DOTATATE in Neuroendocrine Tumor Patients
    Pauwels, E.
    Cleeren, F.
    Tshibangu, T.
    Koole, M.
    Serdons, K.
    Dekervel, J.
    Van Cutsem, E.
    Verslype, C.
    Van Laere, K.
    Bormans, G.
    Deroose, C. M.
    NEUROENDOCRINOLOGY, 2020, 110 : 269 - 269
  • [39] In Vivo Evaluation of 18F-SiFAlin-Modified TATE: A Potential Challenge for 68Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET
    Niedermoser, Sabrina
    Chin, Joshua
    Waengler, Carmen
    Kostikov, Alexey
    Bernard-Gauthier, Vadim
    Vogler, Nils
    Soucy, Jean-Paul
    McEwan, Alexander J.
    Schirrmacher, Ralf
    Waengler, Bjoern
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (07) : 1100 - 1105
  • [40] 68Ga-DOTATATE and 18F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity
    Chang, Chian A.
    Pattison, David A.
    Tothill, Richard W.
    Kong, Grace
    Akhurst, Tim J.
    Hicks, Rodney J.
    Hofman, Michael S.
    CANCER IMAGING, 2016, 16
12345